Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Leukocyte Heparanase: A Double-Edged Sword in Tumor Progression.

Mayfosh AJ, Baschuk N, Hulett MD.

Front Oncol. 2019 Apr 29;9:331. doi: 10.3389/fonc.2019.00331. eCollection 2019. Review.

2.

Neoadjuvant Interferons: Critical for Effective PD-1-Based Immunotherapy in TNBC.

Brockwell NK, Owen KL, Zanker D, Spurling A, Rautela J, Duivenvoorden HM, Baschuk N, Caramia F, Loi S, Darcy PK, Lim E, Parker BS.

Cancer Immunol Res. 2017 Oct;5(10):871-884. doi: 10.1158/2326-6066.CIR-17-0150. Epub 2017 Aug 28.

3.

NK cell heparanase controls tumor invasion and immune surveillance.

Putz EM, Mayfosh AJ, Kos K, Barkauskas DS, Nakamura K, Town L, Goodall KJ, Yee DY, Poon IK, Baschuk N, Souza-Fonseca-Guimaraes F, Hulett MD, Smyth MJ.

J Clin Invest. 2017 Jun 30;127(7):2777-2788. doi: 10.1172/JCI92958. Epub 2017 Jun 5.

4.

Endogenous Il10 alleviates the systemic antiviral cellular immune response and T cell-mediated immunopathology in select organs of acutely LCMV-infected mice.

Jakobshagen K, Ward B, Baschuk N, Huss S, Brunn A, Malecki M, Fiolka M, Rappl G, Corogeanu D, Karow U, Schiller P, Abken H, Heukamp LC, Deckert M, Krönke M, Utermöhlen O.

Am J Pathol. 2015 Nov;185(11):3025-38. doi: 10.1016/j.ajpath.2015.07.019.

PMID:
26506472
5.

Loss of Host Type-I IFN Signaling Accelerates Metastasis and Impairs NK-cell Antitumor Function in Multiple Models of Breast Cancer.

Rautela J, Baschuk N, Slaney CY, Jayatilleke KM, Xiao K, Bidwell BN, Lucas EC, Hawkins ED, Lock P, Wong CS, Chen W, Anderson RL, Hertzog PJ, Andrews DM, Möller A, Parker BS.

Cancer Immunol Res. 2015 Nov;3(11):1207-17. doi: 10.1158/2326-6066.CIR-15-0065. Epub 2015 Jul 21.

6.

Bone specific immunity and its impact on metastasis.

Baschuk N, Rautela J, Parker BS.

Bonekey Rep. 2015 Apr 15;4:665. doi: 10.1038/bonekey.2015.32. eCollection 2015. Review.

7.

Eliminating hepatitis B by antagonizing cellular inhibitors of apoptosis.

Ebert G, Allison C, Preston S, Cooney J, Toe JG, Stutz MD, Ojaimi S, Baschuk N, Nachbur U, Torresi J, Silke J, Begley CG, Pellegrini M.

Proc Natl Acad Sci U S A. 2015 May 5;112(18):5803-8. doi: 10.1073/pnas.1502400112. Epub 2015 Apr 20.

8.

Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus.

Ebert G, Preston S, Allison C, Cooney J, Toe JG, Stutz MD, Ojaimi S, Scott HW, Baschuk N, Nachbur U, Torresi J, Chin R, Colledge D, Li X, Warner N, Revill P, Bowden S, Silke J, Begley CG, Pellegrini M.

Proc Natl Acad Sci U S A. 2015 May 5;112(18):5797-802. doi: 10.1073/pnas.1502390112. Epub 2015 Apr 20.

9.

The interaction of KIR3DL1*001 with HLA class I molecules is dependent upon molecular microarchitecture within the Bw4 epitope.

Saunders PM, Vivian JP, Baschuk N, Beddoe T, Widjaja J, O'Connor GM, Hitchen C, Pymm P, Andrews DM, Gras S, McVicar DW, Rossjohn J, Brooks AG.

J Immunol. 2015 Jan 15;194(2):781-789. doi: 10.4049/jimmunol.1402542. Epub 2014 Dec 5.

10.

NK cell intrinsic regulation of MIP-1α by granzyme M.

Baschuk N, Wang N, Watt SV, Halse H, House C, Bird PI, Strugnell R, Trapani JA, Smyth MJ, Andrews DM.

Cell Death Dis. 2014 Mar 13;5:e1115. doi: 10.1038/cddis.2014.74.

11.

TNF-receptor-1 adaptor protein FAN mediates TNF-induced B16 melanoma motility and invasion.

Boecke A, Carstens AC, Neacsu CD, Baschuk N, Haubert D, Kashkar H, Utermöhlen O, Pongratz C, Krönke M.

Br J Cancer. 2013 Jul 23;109(2):422-32. doi: 10.1038/bjc.2013.242. Epub 2013 May 14.

12.

Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells.

Andrews DM, Sullivan LC, Baschuk N, Chan CJ, Berry R, Cotterell CL, Lin J, Halse H, Watt SV, Poursine-Laurent J, Wang CR, Scalzo AA, Yokoyama WM, Rossjohn J, Brooks AG, Smyth MJ.

Nat Immunol. 2012 Dec;13(12):1171-7. doi: 10.1038/ni.2468. Epub 2012 Nov 11. Erratum in: Nat Immunol. 2013 Apr;14(4):413.

13.

A critical role for granzymes in antigen cross-presentation through regulating phagocytosis of killed tumor cells.

Hoves S, Sutton VR, Haynes NM, Hawkins ED, Fernández Ruiz D, Baschuk N, Sedelies KA, Schnurr M, Stagg J, Andrews DM, Villadangos JA, Trapani JA.

J Immunol. 2011 Aug 1;187(3):1166-75. doi: 10.4049/jimmunol.1001670. Epub 2011 Jun 27.

14.

5' Triphosphorylated small interfering RNAs control replication of hepatitis B virus and induce an interferon response in human liver cells and mice.

Ebert G, Poeck H, Lucifora J, Baschuk N, Esser K, Esposito I, Hartmann G, Protzer U.

Gastroenterology. 2011 Aug;141(2):696-706, 706.e1-3. doi: 10.1053/j.gastro.2011.05.001. Epub 2011 May 13.

PMID:
21684282
15.

Immunologic hurdles of therapeutic stem cell transplantation.

Utermöhlen O, Baschuk N, Abdullah Z, Engelmann A, Siebolts U, Wickenhauser C, Stocking C, Krönke M.

Biol Chem. 2009 Oct;390(10):977-83. doi: 10.1515/BC.2009.114. Review.

PMID:
19642871
16.

Interleukin-4 impairs granzyme-mediated cytotoxicity of Simian virus 40 large tumor antigen-specific CTL in BALB/c mice.

Baschuk N, Utermöhlen O, Gugel R, Warnecke G, Karow U, Paulsen D, Brombacher F, Krönke M, Deppert W.

Cancer Immunol Immunother. 2007 Oct;56(10):1625-36. Epub 2007 Apr 13.

PMID:
17431618
17.

Serpin-6 expression protects embryonic stem cells from lysis by antigen-specific CTL.

Abdullah Z, Saric T, Kashkar H, Baschuk N, Yazdanpanah B, Fleischmann BK, Hescheler J, Krönke M, Utermöhlen O.

J Immunol. 2007 Mar 15;178(6):3390-9.

Supplemental Content

Loading ...
Support Center